Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Child Neurology
•
Neurodevelopmental Disabilities
How do you assess efficacy when trialing a patient with Rett syndrome on trofinetide (Daybue)?
Related Questions
How do you counsel patients and caregivers on dietary interventions for autism?
What pharmacological management do you consider for self-injurious behavior in patients with autism spectrum disorder?
How do you decide when to pursue genetic testing for cerebral palsy?
What behavioral interventions have you found most effective for managing self-injurious behavior in autism?
How do you counsel parents of patients with Autism Spectrum Disorder regarding the limitations of medications without engaging in behavioral or family interventions?
Which interventions have you found effective for managing sensory sensitivities in children with autism spectrum disorder?
What pharmacological management do you consider in patients with Autism Spectrum Disorder whose primary behavior is aggression?
What is your approach to helping parents manage sleep disturbances in patients with autism spectrum disorder?
Would you recommend a specific workup or change in management for patients with severe, persistent deficits from methotrexate leukoencephalopathy?
What workup do you consider for a developmentally typical child with multiple large café au lait macules but no other signs of neurofibromatosis?
